Antiviral Susceptibility of Avian and Swine Influenza Virus of the N1 Neuraminidase Subtype (cid:1)
暂无分享,去创建一个
R. Webster | D. Stallknecht | R. DuBois | M. Gramer | E. Govorkova | S. Krauss | D. Senne | T. DeLiberto | S. Swafford | N. Negovetich | Terri D. Stoner | T. Deliberto
[1] J. Stockman. H1N1 2009 influenza virus infection during pregnancy in the USA , 2011 .
[2] R. Webster,et al. Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. , 2010, The Journal of general virology.
[3] Hiroaki Tanaka,et al. Oseltamivir Carboxylate, the Active Metabolite of Oseltamivir Phosphate (Tamiflu), Detected in Sewage Discharge and River Water in Japan , 2009, Environmental health perspectives.
[4] P. Collins,et al. Structural basis for oseltamivir resistance of influenza viruses. , 2009, Vaccine.
[5] W. Wu. Control of avian influenza A H5N1 in China. , 2009, The Lancet. Infectious diseases.
[6] M. Peacey,et al. Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[7] Ron A M Fouchier,et al. Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.
[8] Yi Guan,et al. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[9] David Smith,et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. , 2009, Antiviral research.
[10] J. Fick,et al. Detection of the Antiviral Drug Oseltamivir in Aquatic Environments , 2009, PloS one.
[11] Gavin J. D. Smith,et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic , 2009, Nature.
[12] Jon Cohen. Swine flu outbreak. New details on virus's promiscuous past. , 2009, Science.
[13] J. Taubenberger,et al. Pandemic influenza--including a risk assessment of H5N1. , 2009, Revue scientifique et technique.
[14] J. van de Kassteele,et al. Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season , 2009, Emerging infectious diseases.
[15] Lynnette Brammer,et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. , 2009, JAMA.
[16] A. Lackenby,et al. Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08 , 2009, Emerging infectious diseases.
[17] Makoto Ujike,et al. Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City, Japan, during the 2007-2008 influenza season. , 2009, Japanese journal of infectious diseases.
[18] Tanja Popovic,et al. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[19] A. Osterhaus,et al. Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques. , 2008, Antiviral research.
[20] Larisa V. Gubareva,et al. Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008 , 2008, Antimicrobial Agents and Chemotherapy.
[21] S. van der Werf,et al. Enzymatic Properties of the Neuraminidase of Seasonal H1N1 Influenza Viruses Provide Insights for the Emergence of Natural Resistance to Oseltamivir , 2008, PLoS pathogens.
[22] G. Boivin,et al. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes. , 2008, Antiviral research.
[23] M. Zambon,et al. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[24] Mats Tysklind,et al. Antiviral Oseltamivir Is not Removed or Degraded in Normal Sewage Water Treatment: Implications for Development of Resistance by Influenza A Virus , 2007, PloS one.
[25] R. Webster,et al. Evolution of influenza A viruses in wild birds , 2007 .
[26] R. Webster,et al. H5N1 influenza--continuing evolution and spread. , 2006, The New England journal of medicine.
[27] I. Stephenson,et al. Use of neuraminidase inhibitors to combat pandemic influenza. , 2006, The Journal of antimicrobial chemotherapy.
[28] R. Webster,et al. Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza Viruses , 2006, Journal of Virology.
[29] Catherine Macken,et al. Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use , 2006, Antimicrobial Agents and Chemotherapy.
[30] P. Agarwal. Enzymes: An integrated view of structure, dynamics and function , 2006, Microbial cell factories.
[31] A. Moscona,et al. Oseltamivir resistance--disabling our influenza defenses. , 2005, The New England journal of medicine.
[32] Yi Guan,et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. , 2005, The New England journal of medicine.
[33] Jeffery K. Taubenberger,et al. Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.
[34] A. Osterhaus,et al. Mallards and Highly Pathogenic Avian Influenza Ancestral Viruses, Northern Europe , 2005, Emerging infectious diseases.
[35] B. Lina,et al. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. , 2005, Antiviral research.
[36] Y Li,et al. The evolution of H5N1 influenza viruses in ducks in southern China. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[37] Y. Guan,et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.
[38] F. Hayden,et al. Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir , 2003, Antimicrobial Agents and Chemotherapy.
[39] I. Barr,et al. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia. , 2003, Communicable diseases intelligence quarterly report.
[40] Larisa V. Gubareva,et al. Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants , 2001, Antimicrobial Agents and Chemotherapy.
[41] R. Webster,et al. Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses , 2001, Antimicrobial Agents and Chemotherapy.
[42] R. Webster,et al. Influenza: an emerging disease. , 1998, Emerging infectious diseases.
[43] N. Bovin,et al. Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. , 1998, Virology.
[44] R. Webster,et al. A pandemic warning? , 1997, Nature.
[45] R. Webster,et al. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en , 1997, Journal of virology.
[46] M. Potier,et al. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. , 1979, Analytical biochemistry.
[47] C. Dolea,et al. World Health Organization , 1949, International Organization.